Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV- infected adults

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 725-728

  King Jr , James C ^a,h   Treanor, John ^d   Fast, Patricia E ^e   Wolff, Mark ^b   Yan, Lihan ^b   Iacuzio, Dominic ^c,g   Readmond, Bernard ^a   O'Brien, Diane ^d   Mallon, Kenneth ^e   Highsmith, William E ^a   Lambert, John S ^a   Belshe, Robert B ^f  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e MEDIMMUNE   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOFFMANN LA ROCHE INC   (United States)

^h University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; COUGHING; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NOSE IRRITATION; PRIORITY JOURNAL; RNA ANALYSIS; SORE THROAT; T LYMPHOCYTE; VIRUS INFECTION; VIRUS SHEDDING;

ADULT; ANTIBODIES, VIRAL; COLD; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; MALE; RNA, VIRAL; VACCINATION; VACCINES, ATTENUATED; VIRUS SHEDDING;

EID: 0034051823     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315246     Document Type: Article

References (15)

1. King JC, Lagos R, Bernstein DI, et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis 1998;177:1394-7.
2. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998;338:1405-12.
3. Nichol KL, Mendelman PM, Mallon KF, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults. JAMA 1999;282:137-44.
4. Treanor JJ, Kotloff K, Betts RF, et al. Efficacy of trivalent, live, cold-adapted influenza vaccine (CAIV-T) in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2) and B viruses. Vaccine 2000;18:899-906.
5. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.
6. Wright P, Bhargava M, Johnson P, Thompson J, Karzon D. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes. Vaccine 1985;3:305-8.
7. + lymphocyte counts above 500 × 10°/L. AIDS 1997;11:53-7.
8. Evans KD, Kline MW. Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus infected child. Pediatr Infect Dis J 1995;14:332-4.
9. McIntosh K. Respiratory viral infections. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV-infection in infants, children and adolescents. 2d ed. Baltimore: Williams & Wilkins, 1994:365-76.
10. Rosok B, Voltersik P, Bjerknes R, et al. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 1996;104:203-7.
11. Tasker SA, O'Brien WA, Treanor JJ, et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 1998;16:1039-42.
12. Yerly S, Wunderli W, Wyler CA, et al. Influenza immunization of HIV-1 infected patients does not increase HIV-1 viral load. AIDS 1994;8:1503-4.
13. Glesby MJ, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 1996;174:1332-6.
14. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-6):1-26.
15. Wright PF, Karzon DT. Live attenuated influenza vaccines. Prog Med Virol 1987;34:70-88.